Expression of annexin I, II, V, and VI by rat osteoblasts in primary culture: Stimulation of annexin I expression by dexamethasone
Open Access
- 1 October 1993
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 8 (10) , 1201-1210
- https://doi.org/10.1002/jbmr.5650081007
Abstract
To determine whether rat osteoblasts synthesize proteins of the annexin family and to evaluate the extent to which glucocorticoids modulate the expression of annexins by these cells, osteoblasts were grown in primary cultures in the absence or presence of dexamethasone, and the expression of annexins was evaluated by immunoblotting using polyclonal antibodies against human annexins. Four different annexins (I, II, V, and VI) were found to be expressed by rat osteoblasts. The expression of annexin I, but not the other annexins studied, was increased in osteoblasts cultured in the presence of dexamethasone (173 ± 33% increase comparing untreated cells and cells treated for 10 days with 5 × 10−7 M dexamethasone). Increased expression of annexin I was observed after the third day of exposure to dexamethasone and rose thereafter until day 10; annexin I expression increased with dexamethasone concentrations above 10−10 M throughout the range of concentrations studied. The increase in annexin I protein was associated with an increase in annexin I mRNA and was completely blocked by the concomitant addition of the glucocorticoid receptor antagonist RU 38486. The increase in annexin I content following dexamethasone treatment was associated with an increase in alkaline phosphatase activity and PTH-induced cAMP stimulation, whereas phospholipase A2 activity in the culture medium was reduced to undetectable levels. The finding that four annexins are expressed in rat osteoblasts in primary culture raises the possibility that these proteins could play an important role in bone formation by virtue of their ability to bind calcium and phospholipids, serve as Ca2+ channels, interact with cytoskeletal elements, and/or regulate phospholipase A2 activity. In addition, the dexamethasone-induced increase in annexin I may represent a mechanism by which glucocorticoids modify osteoblast function.Keywords
This publication has 43 references indexed in Scilit:
- Dexamethasone induces the expression of the mRNA of lipocortin 1 and 2 and the release of lipocortin 1 and 5 in differentiated, but not undifferentiated U‐937 cellsFEBS Letters, 1991
- Expression of bone matrix proteins associated with mineralized tissue formation by adult rat bone marrow cells in vitro: Inductive effects of dexamethasone on the osteoblastic phenotypeJournal of Cellular Physiology, 1991
- Identification and characterization of phospholipase A2 inhibitory proteins in human mononuclear cellsEuropean Journal of Biochemistry, 1990
- A defective cell surface collagen-binding protein in dermatosparactic sheep fibroblasts.The Journal of cell biology, 1988
- Purification and characterization of a 32‐kDa phospholipase A2 inhibitory protein (lipocortin) from human peripheral blood mononuclear cellsFEBS Letters, 1987
- Production of osteocalcin by human bone cells in vitro. Effects of 1,25(OH)2D3, 24,25(OH)2D3, parathyroid hormone, and glucocorticoidsMetabolic Bone Disease and Related Research, 1984
- Glucocorticoid Receptors and Actions in Subpopulations of Cultured Rat Bone CellsJournal of Clinical Investigation, 1979
- The role of synthetic and bone extracted Ca-phospholipid-PO4 complexes in hydroxyapatite formationCalcified Tissue International, 1977
- Separation of parathyroid hormone and calcitonin-sensitive cells from non-responsive bone cellsNature, 1974
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970